Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Inflammatory breast cancer: what we know and what we need to learn.

Yamauchi H, Woodward WA, Valero V, Alvarez RH, Lucci A, Buchholz TA, Iwamoto T, Krishnamurthy S, Yang W, Reuben JM, Hortobágyi GN, Ueno NT.

Oncologist. 2012;17(7):891-9. doi: 10.1634/theoncologist.2012-0039. Epub 2012 May 14. Review.

2.

What radiologists need to know about diagnosis and treatment of inflammatory breast cancer: a multidisciplinary approach.

Yeh ED, Jacene HA, Bellon JR, Nakhlis F, Birdwell RL, Georgian-Smith D, Giess CS, Hirshfield-Bartek J, Overmoyer B, Van den Abbeele AD.

Radiographics. 2013 Nov-Dec;33(7):2003-17. doi: 10.1148/rg.337135503.

PMID:
24224593
3.

Trimodal therapy for inflammatory breast cancer: a surgeon's perspective.

Li BD, Sicard MA, Ampil F, Abreo F, Lilien D, Chu QD, Burton GV.

Oncology. 2010;79(1-2):3-12. doi: 10.1159/000318529. Epub 2010 Nov 3. Review.

PMID:
21051912
4.

Inflammatory breast cancer: an overview.

van Uden DJ, van Laarhoven HW, Westenberg AH, de Wilt JH, Blanken-Peeters CF.

Crit Rev Oncol Hematol. 2015 Feb;93(2):116-26. doi: 10.1016/j.critrevonc.2014.09.003. Epub 2014 Oct 16. Review.

PMID:
25459672
5.

Inflammatory breast cancer: the disease, the biology, the treatment.

Robertson FM, Bondy M, Yang W, Yamauchi H, Wiggins S, Kamrudin S, Krishnamurthy S, Le-Petross H, Bidaut L, Player AN, Barsky SH, Woodward WA, Buchholz T, Lucci A, Ueno NT, Cristofanilli M.

CA Cancer J Clin. 2010 Nov-Dec;60(6):351-75. doi: 10.3322/caac.20082. Epub 2010 Oct 19. Review. Erratum in: CA Cancer J Clin. 2011 Mar-Apr;61(2):134. Ueno, Naoto [corrected to Ueno, Naoto T].

6.

Lessons learned from an unusual case of inflammatory breast cancer.

Harrison AM, Zendejas B, Ali SM, Scow JS, Farley DR.

J Surg Educ. 2012 May-Jun;69(3):350-4. doi: 10.1016/j.jsurg.2011.10.016. Review.

PMID:
22483137
7.

Inflammatory breast cancer.

Dushkin H, Cristofanilli M.

J Natl Compr Canc Netw. 2011 Feb;9(2):233-40; quiz 241. Review.

PMID:
21310844
8.

Inflammatory breast cancer: what progress have we made?

Dawood S, Cristofanilli M.

Oncology (Williston Park). 2011 Mar;25(3):264-70, 273. Review.

PMID:
21548470
9.

Pretreatment staging positron emission tomography/computed tomography in patients with inflammatory breast cancer influences radiation treatment field designs.

Walker GV, Niikura N, Yang W, Rohren E, Valero V, Woodward WA, Alvarez RH, Lucci A Jr, Ueno NT, Buchholz TA.

Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):1381-6. doi: 10.1016/j.ijrobp.2011.10.040. Epub 2012 Jan 26.

PMID:
22284689
10.

International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment.

Dawood S, Merajver SD, Viens P, Vermeulen PB, Swain SM, Buchholz TA, Dirix LY, Levine PH, Lucci A, Krishnamurthy S, Robertson FM, Woodward WA, Yang WT, Ueno NT, Cristofanilli M.

Ann Oncol. 2011 Mar;22(3):515-23. doi: 10.1093/annonc/mdq345. Epub 2010 Jul 5.

11.

Initial staging impact of fluorodeoxyglucose positron emission tomography/computed tomography in locally advanced breast cancer.

Niikura N, Liu J, Costelloe CM, Palla SL, Madewell JE, Hayashi N, Yu TK, Tokuda Y, Theriault RL, Hortobagyi GN, Ueno NT.

Oncologist. 2011;16(6):772-82. doi: 10.1634/theoncologist.2010-0378. Epub 2011 May 31.

12.

Long-term follow-up of breast-conserving therapy in patients with inflammatory breast cancer treated with neoadjuvant chemotherapy.

Bonev V, Evangelista M, Chen JH, Su MY, Lane K, Mehta R, Butler J, Hsiang D.

Am Surg. 2014 Oct;80(10):940-3.

13.

Risk factors for locoregional failure in patients with inflammatory breast cancer treated with trimodality therapy.

Saigal K, Hurley J, Takita C, Reis IM, Zhao W, Rodgers SE, Wright JL.

Clin Breast Cancer. 2013 Oct;13(5):335-43. doi: 10.1016/j.clbc.2013.04.002. Epub 2013 Jul 10.

PMID:
23850216
14.

IBC as a Rapidly Spreading Systemic Disease: Clinical and Targeted Approaches Using the Neoadjuvant Model.

Dawood S, Cristofanilli M.

J Natl Cancer Inst Monogr. 2015 May;2015(51):56-9. doi: 10.1093/jncimonographs/lgv017.

PMID:
26063888
15.

Identifying the impact of inflammatory breast cancer on survival: a retrospective multi-center cohort study.

Diessner J, Van Ewijk R, Weiss CR, Janni W, Wischnewsky MB, Kreienberg R, Hancke K, Blettner M, Wöckel A, Schwentner L.

Arch Gynecol Obstet. 2015 Sep;292(3):655-64. doi: 10.1007/s00404-015-3691-4. Epub 2015 Mar 27.

PMID:
25814296
16.

Clinical characteristics and outcome of bone-only metastasis in inflammatory and noninflammatory breast cancers.

Kai M, Kogawa T, Liu DD, Fouad TM, Kai K, Niikura N, Hsu L, Willey JS, Theriault RL, Valero V, Ueno NT.

Clin Breast Cancer. 2015 Feb;15(1):37-42. doi: 10.1016/j.clbc.2014.06.007. Epub 2014 Aug 15.

PMID:
25258308
17.
18.

Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosis.

Fouad TM, Kogawa T, Liu DD, Shen Y, Masuda H, El-Zein R, Woodward WA, Chavez-MacGregor M, Alvarez RH, Arun B, Lucci A, Krishnamurthy S, Babiera G, Buchholz TA, Valero V, Ueno NT.

Breast Cancer Res Treat. 2015 Jul;152(2):407-16. doi: 10.1007/s10549-015-3436-x. Epub 2015 May 29. Erratum in: Breast Cancer Res Treat. 2015 Jul;152(2):417.

19.

Skin thickening as unique pathologic sign of an inflammatory breast cancer: a case report and review of the literature.

Ballesio L, D'Ambrosio I, Ravazzolo N, Angeletti M, Di Pastena F, Tardioli S, Lodise P, Marini M.

Clin Ter. 2011;162(4):351-4. Review.

PMID:
21912823
20.

Long-term treatment efficacy in primary inflammatory breast cancer by hormonal receptor- and HER2-defined subtypes.

Masuda H, Brewer TM, Liu DD, Iwamoto T, Shen Y, Hsu L, Willey JS, Gonzalez-Angulo AM, Chavez-MacGregor M, Fouad TM, Woodward WA, Reuben JM, Valero V, Alvarez RH, Hortobagyi GN, Ueno NT.

Ann Oncol. 2014 Feb;25(2):384-91. doi: 10.1093/annonc/mdt525. Epub 2013 Dec 18.

Supplemental Content

Support Center